These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12846777)

  • 21. [Pathology of diabetic nephropathy].
    Kanauchi M; Shiiki H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():270-4. PubMed ID: 12430240
    [No Abstract]   [Full Text] [Related]  

  • 22. The emerging role of VEGF in diabetic kidney disease.
    Khamaisi M; Schrijvers BF; De Vriese AS; Raz I; Flyvbjerg A
    Nephrol Dial Transplant; 2003 Aug; 18(8):1427-30. PubMed ID: 12897074
    [No Abstract]   [Full Text] [Related]  

  • 23. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Kidney tubular function in diabetes mellitus].
    Bazarova AV; Mamaeva GG; Karelin AA
    Probl Endokrinol (Mosk); 1990; 36(3):87-91. PubMed ID: 2204054
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnostic value of the aminopeptidase N, N-acetyl-beta-D-glucosaminidase and dipeptidylpeptidase IV in evaluating tubular dysfunction in patients with glomerulopathies.
    Mitic B; Lazarevic G; Vlahovic P; Rajic M; Stefanovic V
    Ren Fail; 2008; 30(9):896-903. PubMed ID: 18925530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etiologic variability of nephropathy in juvenile diabetes mellitus.
    Gilboa N; Durante D; McIntosh RM; Guggenheim S
    Arch Pathol Lab Med; 1979 Aug; 103(9):479-82. PubMed ID: 582380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition and reversibility of renal changes: lessons from diabetic kidney disease.
    Flyvbjerg A
    Acta Paediatr Suppl; 2006 Apr; 95(451):83-92. PubMed ID: 16720472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transformation of interstitial fibroblasts and tubulointerstitial fibrosis in diabetic nephropathy.
    Ina K; Kitamura H; Tatsukawa S; Takayama T; Fujikura Y; Shimada T
    Med Electron Microsc; 2002 Jun; 35(2):87-95. PubMed ID: 12181650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on mechanisms of proteinuria using amino-acid-induced inhibition of tubular reabsorption in normal and diabetic man.
    Mogensen CE; Sølling K; Vittinghus E
    Contrib Nephrol; 1981; 26():50-65. PubMed ID: 6793305
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.
    Schrijvers BF; Flyvbjerg A; De Vriese AS
    Kidney Int; 2004 Jun; 65(6):2003-17. PubMed ID: 15149314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-1 microglobulin: a marker for early detection of tubular disorders in diabetic nephropathy.
    Shore N; Khurshid R; Saleem M
    J Ayub Med Coll Abbottabad; 2010; 22(4):53-5. PubMed ID: 22455261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Functional study of diabetic nephropathies. A].
    Mincu I; Pieptea R; Mihalache N
    Med Interna (Bucur); 1969 Oct; 21(10):1187-98. PubMed ID: 5365993
    [No Abstract]   [Full Text] [Related]  

  • 33. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration.
    Thomson SC; Vallon V; Blantz RC
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F8-15. PubMed ID: 14656757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Navigating pathways affecting type 1 diabetic kidney disease.
    Pasquali L; Trucco M; Ringquist S
    Pediatr Diabetes; 2007 Oct; 8(5):307-22. PubMed ID: 17850474
    [No Abstract]   [Full Text] [Related]  

  • 35. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.
    Lindenmeyer MT; Kretzler M; Boucherot A; Berra S; Yasuda Y; Henger A; Eichinger F; Gaiser S; Schmid H; Rastaldi MP; Schrier RW; Schlöndorff D; Cohen CD
    J Am Soc Nephrol; 2007 Jun; 18(6):1765-76. PubMed ID: 17475821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent diabetic nephropathy in renal allografts placed in diabetic patients and protective effect of simultaneous pancreatic transplantation.
    Bohman SO; Wilczek H; Tydén G; Jaremko G; Lundgren G; Groth CG
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2290-3. PubMed ID: 3547924
    [No Abstract]   [Full Text] [Related]  

  • 37. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
    Ninichuk V; Kulkarni O; Clauss S; Anders H-
    Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of VEGF in kidney of diabetic rats].
    Chen ZJ; Yang YB; Huang SM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):633-6. PubMed ID: 17718428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
    Wang SN; LaPage J; Hirschberg R
    Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocannabinoids and the renal proximal tubule: an emerging role in diabetic nephropathy.
    Jenkin KA; Verty AN; McAinch AJ; Hryciw DH
    Int J Biochem Cell Biol; 2012 Nov; 44(11):2028-31. PubMed ID: 22842535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.